Navigating the Future: Point-of-Care (POC) Coagulation Testing Market Trends and Forecast Insights, 2025 Edition

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_
_x000D_
Point-of-Care (POC) Coagulation Testing Market Size Growth Forecast: What to Expect by 2025?_x000D_
The market size of point-of-care (poc) coagulation testing has seen robust growth in recent times. The market value, which stands at $1.18 billion in 2024, is projected to reach $1.25 billion in 2025, with a compound annual growth rate (CAGR) of 5.4%. Factors such as increased patient needs, growing preference for point-of-care testing, reliability of coagulation status on the PT test, automation and incorporation with Electronic Health Records (EHRs), and the escalating cases of cardiovascular diseases and blood disorders have all significantly contributed to this growth during the historic period._x000D_
_x000D_
How Will the Point-of-Care (POC) Coagulation Testing Market Size Evolve and Grow by 2029?_x000D_
In the upcoming years, the point-of-care coagulation testing market size is projected to witness a stable rise. It is slated to inflate to an impressive $1.47 billion in 2029, boasting a Compound Annual Growth Rate (CAGR) of 4.2%. Several factors collectively contribute to its increase during the forecast period, including a surge in usage in healthcare settings, escalating demand in homecare environments, and a growing incidence of chronic blood diseases. The target consumers' need for quick, reliable testing, and the increased uptake of point-of-care testing fuels its progress. Major market trends during the forecast period are predicted to be technological advancements, a soaring demand from developed nations, broadening healthcare applications, COVID-19's impact, and the adoption of multiplex POC diagnostics._x000D_
_x000D_
View the full report here: _x000D_
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report_x000D_
_x000D_
What Drivers Are Propelling the Growth of Point-of-Care (POC) Coagulation Testing Market Forward?_x000D_
The escalating occurrence of heart-related disorders is anticipated to drive expansion in the point-of-care (POC) coagulation testing industry. Cardiovascular diseases (CVDs), also known as heart and blood vessel disorders, encompass conditions such as coronary heart ailments, cerebrovascular disease, and peripheral arterial disease. POC coagulation tests are critical for the treatment of CVDs, given that they offer live data regarding a patients' clotting status, allowing for timely decisions about clotting interventions and minimizing the potential for bleeding complications post cardiac operations. To illustrate, a report from the Switzerland-based World Heart Federation in October 2022 projected an increased death rate due to cardiovascular disease. The report forecasted CVD-related fatalities rising from roughly 18.9 million in 2020 to over 22.2 million by 2030, further escalating to 32.3 million by 2050. Consequently, the growing prevalence of cardiovascular diseases is fueling the expansion of the POC coagulation testing market._x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp_x000D_
_x000D_
What Are the Key Trends Driving Point-of-Care (POC) Coagulation Testing Market Growth?_x000D_
Leading businesses in the point-of-care (POC) coagulation testing market are focusing on strategic partnerships for market dominance. Strategic alliance is a defined agreement among multiple parties to collectively work towards achieving shared, pre-set objectives. In January 2023, for example, Jana care, an American company that develops biomarker assays for its own digital health platform, entered into partnership with Roche Diagnostics, a Switzerland-based company known for developing diagnostic tools, tests, and digital solutions that revolutionise healthcare. The partnership is aimed at creating and distributing a POC blood testing platform intended for chronic kidney disease and heart failure screening. This groundbreaking platform will allow patients to conduct blood tests from home, while clinicians review the results remotely._x000D_
_x000D_
What Are the Key Segments in the Point-of-Care (POC) Coagulation Testing Market?_x000D_
The point-of-care (poc) coagulation testing market covered in this report is segmented - _x000D_
_x000D_
1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology_x000D_
2) By Distribution Channel: Direct Tenders, Retail_x000D_
3) By End-User: Hospitals, Clinics, Home care_x000D_
_x000D_
Subsegments:_x000D_
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection_x000D_
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection_x000D_
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection_x000D_
_x000D_
Tailor your insights and customize the full report here:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=13913&type=smp_x000D_
_x000D_
Who Are the Key Players Shaping the Point-of-Care (POC) Coagulation Testing Market's Competitive Landscape?_x000D_
Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc_x000D_
_x000D_
What Geographic Markets Are Powering Growth in the Point-of-Care (POC) Coagulation Testing Market?_x000D_
North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (POC) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
Purchase the full report today:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13913_x000D_
_x000D_
This Report Supports:_x000D_
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions._x000D_
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning._x000D_
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks._x000D_
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work._x000D_
_x000D_

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.